Predictive Value of a SNP Signature and Liquid Biopsy in Natural Killer T-cell Lymphoma

Studying Gene Expression in Samples From Younger Patients With Neuroblastoma

NCT01553448 ·Status: COMPLETED

Tertiary Lymphoid Structures Related Genes Predicting Prognosis in Clear Cell Renal Cell Carcinoma: a Retrospective Cohort Study

NCT06883565 ·Status: COMPLETED

Clinical Application of Liquid Biopsy for Precise Diagnosis and Prognosis in Lymphoma

NCT04062877 ·Status: COMPLETED

Prospectively Predict the Immunotherapy Response of Gastric Cancer Based on Circulating Exosomal LncRNA-GC1 Biopsy

NCT05334849 ·Status: COMPLETED

Correlation Between Driver Gene Abnormalities and Clinicopathological Characteristics and Disease Prognosis in Lymphoma

NCT04263935 ·Status: RECRUITING

Studying Genes Associated With Non-Hodgkin Lymphoma in Young Patients

NCT01623856 ·Status: COMPLETED

Use of a Liquid Biopsy Signature to Detect Early-onset Gastric Cancer

NCT06023121 ·Status: COMPLETED

Diagnostic Study of Patients With Aggressive Non-Hodgkin's Lymphoma

NCT00003863 ·Status: COMPLETED

Effectiveness of Circulating DNA for Predicting the Relapse and Overall Survival in NHL Patients

NCT03079947 ·Status: UNKNOWN

Studying Tumor Tissue Samples From Patients With Melanoma Who Have Undergone Sentinel Lymph Node Biopsy

NCT00897481 ·Status: UNKNOWN

Study on the Contribution of the Genetic Tumor Profile Obtained by Circulating Tumor DNA Analysis in the Multidisciplinary Molecular Biology Meeting of Eastern PACA

NCT06606366 ·Status: RECRUITING ·Phase: NA

Molecular and Genomic Profiling of Head and Neck Tumors

NCT00200486 ·Status: RECRUITING

Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia

NCT01005368 ·Status: COMPLETED

Evaluation of Autologous Natural Killer Cell Activity in Primary Cancer Cell Cultures

NCT05869994 ·Status: WITHDRAWN

Biomarker Expression in Samples From Young Patients With Anaplastic Large Cell Lymphoma

NCT01366170 ·Status: COMPLETED

Serum Histone Succinylation as a Novel Prognostic Biomarker in Hematological Malignancies

NCT07131449 ·Status: NOT_YET_RECRUITING

Assessment of Early-detection Based on Liquid Biopsy in Lymphoid Malignancies

NCT05275036 ·Status: UNKNOWN

Plasma Circulating Deoxyribonucelic Acid (DNA) as a Response Marker

NCT00318604 ·Status: UNKNOWN

Early Assessment of Lymphoma Treatment Response Using Phased Variant Analysis With Next-Generation Sequencing

NCT06550427 ·Status: RECRUITING

Studying Genes in Samples From Younger Patients With Rhabdomyosarcoma

NCT01585376 ·Status: COMPLETED

Detection of Melanoma Markers in Lymph Nodes or Peripheral Blood of Patients With Melanoma

NCT00004153 ·Status: COMPLETED ·Phase: NA

Biomarker Differences in Samples From Patients With Undifferentiated Sarcomas

NCT01802125 ·Status: COMPLETED

Genetic Analysis Using Blood or Bone Marrow From Participants With Neuroblastoma or Noncancerous Conditions

NCT00436696 ·Status: COMPLETED

Research on the Heterogeneity of Taiwanese Breast Cancer Patients by Next Generation Sequencing (NGS) Tools

NCT04626440 ·Status: RECRUITING

Potential Clinical Utilities of Circulating Tumor DNA in Advanced HER2 Negative Gastric Cancer

NCT05513144 ·Status: UNKNOWN